TOMSK, RUSSIA / RankWire.AI / – Russian researchers have successfully created and evaluated a bioactive coating for titanium orthopaedic devices. This coating incorporates calcium phosphate derived from hydroxyapatite and contains nitrogen compounds associated with nitric oxide production. Laboratory experiments revealed that human mesenchymal stem cells exhibited higher survival rates on coated titanium compared to untreated samples. The study also investigated surface chemistry, hardness, thickness, and wettability. Focused on how various gas mixtures alter the coating and its biological effects, the peer-reviewed research provides insight into the material’s potential.
At Tomsk Polytechnic University, the coatings were fabricated using reactive magnetron sputtering within a vacuum chamber. The team employed a hydroxyapatite target and manipulated the nitrogen-to-argon ratio during the deposition process. They tested five different gas conditions, including pure nitrogen and pure argon, observing measurable variations in the coating’s properties. The researchers evaluated surface structure, chemical makeup, mechanical strength, and interaction with liquids. Subsequently, they exposed the coated titanium samples to human mesenchymal stem cells under controlled laboratory environments.
The findings indicated that argon concentrations impacted several physical characteristics of the coatings. Increased argon led to thicker, denser, and harder layers. Chemical analysis identified nitrogen-carbon and nitrogen-oxygen bonds in the modified surfaces. When comparing cell viability on coated versus uncoated titanium, the results showed that the coated samples significantly enhanced cell survival during the testing period. The team also monitored gene expression related to early bone cell development to determine how the coating influenced cellular activity.
Enhanced titanium coatings promote improved cell viability
It was observed that elevated nitrogen levels modulated the activity of certain genes involved in early osteogenic differentiation, with effects becoming evident after seven days of cell culture. Despite these genetic changes, the cells maintained their capacity to produce bone-related tissue. The study was confined to laboratory experiments and did not involve testing in human subjects. Moreover, it did not evaluate clinical outcomes from implants in patients. Therefore, these results demonstrate laboratory performance but do not confirm clinical benefits for joint replacements or other orthopaedic procedures.
The research was conducted by scientists from Immanuel Kant Baltic Federal University and Siberian State Medical University, with additional contributions from researchers at Saint Petersburg State University. Their focus was on how the coating composition influences both material properties and cellular responses. Hydroxyapatite, a widely studied material for medical coatings, mimics the mineral component of human bone due to its calcium phosphate structure. The researchers varied nitrogen exposure during coating fabrication while using hydroxyapatite as the base material.
Future investigations will explore long-term biological effects
The team has outlined plans for additional laboratory and biological testing following their initial seven-day analysis. They aim to monitor stem cell behavior over periods spanning 10 to 28 days and evaluate the dissolution rate of the coatings. Another aspect of their upcoming work involves measuring nitric oxide release into surrounding tissues in living organisms. These further tests are not included in the current publication. Presently, the findings are limited to laboratory measurements, coated titanium samples, and controlled cell experiments.
This research contributes valuable data on how varying nitrogen and argon ratios affect calcium phosphate coatings on titanium implants. The study documents changes in coating thickness, density, hardness, chemical bonding, and cellular response. Under the tested conditions, coated samples consistently supported better survival of stem cells compared to untreated titanium. However, the research remains at a preclinical stage and does not establish safety or efficacy in human patients. Future studies will need to examine additional properties such as long-term cell behavior and nitric oxide release to fully assess clinical relevance.